Induction Fluorouracil-Based Chemotherapy and PET-Adapted Consolidation Chemoradiation with Esophagectomy for High-Risk Gastroesophageal Adenocarcinoma.

MLA

Sinnamon, Andrew J., et al. “Induction Fluorouracil-Based Chemotherapy and PET-Adapted Consolidation Chemoradiation with Esophagectomy for High-Risk Gastroesophageal Adenocarcinoma.” Cancers, vol. 15, no. 17, Sept. 2023, p. 4375. EBSCOhost, https://doi.org/10.3390/cancers15174375.

APA

Sinnamon, A. J., Mehta, R., Saeed, S., Lauwers, G. Y., Palm, R. F., Frakes, J. M., Hoffe, S. E., Baldonado, J. J., Fontaine, J. P., & Pimiento, J. M. (2023). Induction Fluorouracil-Based Chemotherapy and PET-Adapted Consolidation Chemoradiation with Esophagectomy for High-Risk Gastroesophageal Adenocarcinoma. Cancers, 15(17), 4375. https://doi.org/10.3390/cancers15174375

Chicago

Sinnamon, Andrew J., Rutika Mehta, Samir Saeed, Gregory Y. Lauwers, Russell F. Palm, Jessica M. Frakes, Sarah E. Hoffe, Jobelle J. Baldonado, Jacques P. Fontaine, and Jose M. Pimiento. 2023. “Induction Fluorouracil-Based Chemotherapy and PET-Adapted Consolidation Chemoradiation with Esophagectomy for High-Risk Gastroesophageal Adenocarcinoma.” Cancers 15 (17): 4375. doi:10.3390/cancers15174375.